Coverage
-
June 18, 2025
Close to a year after the U.S. Supreme Court shot down an earlier version of its Chapter 11 plan, OxyContin maker Purdue Pharma was before a New York bankruptcy judge Wednesday to ask for permission to send its revised plan out for a creditor vote.
176 other articles on this case.
View all »